EUVIMEDEUVIMED entdecken
Übersichtsarbeit

European Society of Toxicologic Pathology—Pathology 2.0 Mass Spectrometry Imaging Special Interest Group: Mass Spectrometry Imaging in Diagnostic and Toxicologic Pathology for Label-Free Detection of Molecules—From Basics to Practical Applications

Enrico Vezzali iD, Michael Becker, Fernando Romero-Palomo iD, Marjolein van Heerden iD, Caroline Chipeaux iD, Gregory Hamm iD, Dinesh S Bangari iD, Thomas Lemarchand, Barbara Lenz iD, Bogdan Munteanu iD, Bhanu Singh iD, Celine Thuilliez iD und 3 weitere

Toxicologic Pathology · 2025

DOI: 10.1177/01926233241311269 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxicologic Pathology, 2025. Verfasst von Enrico Vezzali und 14 weiteren Autor:innen. Beteiligte Einrichtung: Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland. Hauptthemen laut MEDLINE: Toxicology, Mass Spectrometry, Pathology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mass Spectrometry Imaging (MSI) is a powerful tool to understand molecular pathophysiology and therapeutic and toxicity mechanisms, as well as for patient stratification and precision medicine. MSI, a label-free technique offering detailed spatial information on a large number of molecules in different tissues, encompasses various techniques including Matrix-Assisted Laser Desorption Ionization (MALDI), Desorption Electrospray Ionization (DESI), and Secondary Ion Mass Spectrometry (SIMS) that can be applied in diagnostic and toxicologic pathology. Given the utmost importance of high-quality samples, pathologists play a pivotal role in providing comprehensive pathobiology and histopathology knowledge, as well as information on tissue sampling, orientation, morphology, endogenous biomarkers, and pathogenesis, which are crucial for the correct interpretation of targeted experiments. This article introduces MSI and its fundamentals, and reports on case examples, determining the best suited technology to address research questions. High-level principles and characteristics of the most used modalities for spatial metabolomics, lipidomics and proteomics, sensitivity and specific requirements for sample procurement and preparation are discussed. MSI applications for projects focused on drug metabolism, nonclinical safety assessment, and pharmacokinetics/pharmacodynamics and various diagnostic pathology cases from nonclinical and clinical settings are showcased.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxicologyMass SpectrometryPathologyHumansSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnimalsMetabolomics

Stichwörter der Autor:innen

diagnostic pathologydrug developmentlabel-freemass spectrometry imagingmultiplex

Autor:innen und Institutionen

  • Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
  • Boehringer Ingelheim Pharma GmbH, Biberach an der Riss, Germany.
  • Roche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.
  • Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium.
  • Sanofi R&D, Frankfurt, Germany.
  • AstraZeneca R&D, Cambridge, UK.

ORCID-Profile: Enrico Vezzali, Fernando Romero-Palomo, Marjolein van Heerden, Caroline Chipeaux, Gregory Hamm, Dinesh S Bangari, Barbara Lenz, Bogdan Munteanu, Bhanu Singh, Celine Thuilliez, Seong-Wook Yun, Andrew Smith, Rob Vreeken

Zitieren

APA

Vezzali, E., Becker, M., Romero-Palomo, F., van Heerden, M., Chipeaux, C., Hamm, G., Bangari, D. S., Lemarchand, T., Lenz, B., Munteanu, B., Singh, B., Thuilliez, C., Yun, S. W., Smith, A., & Vreeken, R. (2025). European Society of Toxicologic Pathology—Pathology 2.0 Mass Spectrometry Imaging Special Interest Group: Mass Spectrometry Imaging in Diagnostic and Toxicologic Pathology for Label-Free Detection of Molecules—From Basics to Practical Applications. Toxicologic Pathology. https://doi.org/10.1177/01926233241311269

Vancouver

Vezzali E, Becker M, Romero-Palomo F, van Heerden M, Chipeaux C, Hamm G, et al. European Society of Toxicologic Pathology—Pathology 2.0 Mass Spectrometry Imaging Special Interest Group: Mass Spectrometry Imaging in Diagnostic and Toxicologic Pathology for Label-Free Detection of Molecules—From Basics to Practical Applications. Toxicologic Pathology. 2025. doi:10.1177/01926233241311269

BibTeX
@article{Vezzali2025,
  author = {Vezzali, Enrico and Becker, Michael and Romero-Palomo, Fernando and van Heerden, Marjolein and Chipeaux, Caroline and Hamm, Gregory and Bangari, Dinesh S and Lemarchand, Thomas and Lenz, Barbara and Munteanu, Bogdan and Singh, Bhanu and Thuilliez, Celine and Yun, Seong-Wook and Smith, Andrew and Vreeken, Rob},
  title = {European Society of Toxicologic Pathology—Pathology 2.0 Mass Spectrometry Imaging Special Interest Group: Mass Spectrometry Imaging in Diagnostic and Toxicologic Pathology for Label-Free Detection of Molecules—From Basics to Practical Applications},
  journal = {Toxicologic Pathology},
  year = {2025},
  doi = {10.1177/01926233241311269}
}
Kostenlos starten →